Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Head and Neck Neoplasms 686Squamous Cell Carcinoma of Head and Neck 203Thyroid Neoplasms 182Mouth Neoplasms 127Oropharyngeal Neoplasms 89Thyroid Nodule 88Breast Neoplasms 73Neoplasms 71Nasopharyngeal Carcinoma 69Laryngeal Neoplasms 65Lung Neoplasms 61Thyroid Cancer, Papillary 42Prostatic Neoplasms 41Carcinoma, Squamous Cell 40Nasopharyngeal Neoplasms 35Esophageal Neoplasms 35Deglutition Disorders 33Stomatitis 32Thyroid Diseases 31Colorectal Neoplasms 30Xerostomia 29Hypopharyngeal Neoplasms 29Uterine Cervical Neoplasms 28Melanoma 25Carcinoma, Non-Small-Cell Lung 24Motor Activity 23Tongue Neoplasms 22Sarcoma 22Pancreatic Neoplasms 22Colonic Neoplasms 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Dihydropyrimidine Dehydrogenase Deficiency × Head & Neck × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡